8-K
Current Report
Contineum Therapeutics, Inc. Filed Acc 0001437749-24-018934
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading cont20240524_8k.htm…